Rtw Investments, LP Cytokinetics Inc Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Rtw Investments, LP holds 2,721,158 shares of CYTK stock, worth $103 Million. This represents 2.09% of its overall portfolio holdings.
Number of Shares
2,721,158
Previous 2,721,158
-0.0%
Holding current value
$103 Million
Previous $144 Million
10.91%
% of portfolio
2.09%
Previous 2.29%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
400Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$557 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$452 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$408 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$234 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$108 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.57B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...